62P A multi-center real-world study of the efficacy and safety of PARP inhibitors in patients with ovarian cancer in SpainRodrigo Sánchez-Bayona, Ainhoa Madariaga, A. Gallego Martínez et al.|ESMO Open|2024Cited by 0